In pharmaceutical manufacturing, the quality of intermediates directly impacts the safety, efficacy, and cost-efficiency of final drug products. 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin (also known as DMH or 1-HMH) is a versatile hydantoin derivative widely used as a pharmaceutical intermediate and in industrial chemical applications. With a purity of over 99%, this compound serves as a key precursor in the synthesis of various therapeutic agents, particularly in oncology and neurology. This article examines the product's specifications, applications, and the manufacturing expertise that Leache has built over more than 30 years in this field.
Hydantoin derivatives have been recognized for decades as valuable scaffolds in medicinal chemistry. Their unique chemical structure allows them to interact with biological targets in ways that enhance drug activity, selectivity, and metabolic stability. Among these derivatives, 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin stands out as a particularly versatile intermediate.
This compound serves multiple functions in drug synthesis. It can act as a pharmacophore itself, directly participating in drug-target interactions. It is also used to construct optically pure drugs, particularly in the development of certain neurological therapies. More recently, hydantoin derivatives have found applications in emerging fields such as PROTAC technology, where they function as CRBN ligands in the design of protein degradation agents for anticancer treatments. Leache, with over 30 years of experience in hydantoin series products, has established itself as a reliable supplier of this essential intermediate to customers in more than 50 countries.
Below is a summary of the key specifications for 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin from Leache.
| Parameter | Specification Details |
| Product Name | 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin |
| CAS Number | 6440-58-0 |
| Appearance | White crystalline powder |
| Purity | ≥99% |
| Moisture Content | ≤0.5% |
| Solubility | Compatible with water and organic solvents |
| Packaging Options | 25kg drums, 500kg containers (palletized), custom packaging available |
The versatility of 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin makes it valuable across multiple sectors.
The compound is a key building block in the synthesis of several therapeutic agents. In antitumor drug development, hydantoin derivatives can function as targeted delivery vehicles. They are also used to construct optically pure drugs, including certain neurological treatments. The compound's role in PROTAC technology—as a CRBN ligand for protein degradation agents—represents an emerging application with significant potential.
Beyond pharmaceuticals, this intermediate is used in water treatment formulations, paints, adhesives, and agricultural chemicals. Its chemical stability and reactivity make it suitable for a range of industrial processes.
The compound is commonly used in research laboratories worldwide for the synthesis of novel chemical entities and for small-batch production of experimental drugs. Its high purity (≥99%) ensures consistent and reliable results in sensitive synthesis procedures.
For pharmaceutical intermediates, quality and packaging are as important as the product itself. Leache pays close attention to both.
Leache has been manufacturing hydantoin series products for over three decades. The company has continuously refined its manufacturing processes to ensure product stability and consistent performance. Each batch is tested for purity and moisture content before release, ensuring that customers receive products that meet the required specifications.
The compound is available in a variety of packaging options to suit different order sizes and handling requirements. Standard packaging includes 25kg drums that provide moisture protection, as well as larger 500kg containers on pallets. Custom packaging solutions are also available upon request. Each shipment is checked to ensure it meets international safety rules and arrives in good condition. Labels and logos are interchangeable, and customers can specify their preferred packaging design.
Leache was founded in 1972 in Handan, Hebei, and has evolved from a regional manufacturer into a modern research and management institution with a global reputation. The company is recognized as a National High-Tech Enterprise and holds numerous patents and international certifications.
Leache is the first domestic company to produce and sell hydantoin series products and remains the earliest and largest bromine disinfectant manufacturer in China. The company operates a high-standard pilot plant that supports R&D and customized production of chemicals involving bromination, chlorination, and cyanide reactions. This capability, combined with modern production lines and a fully automated factory, allows Leache to meet diverse customer requirements.
The company's products are exported to more than 50 countries and regions, with a market share of over 50% in Europe and America. Long-term strategic cooperative relationships with hundreds of well-known enterprises reflect the trust that customers place in Leache's quality and service.
A: It is primarily used as a pharmaceutical intermediate in the synthesis of various therapeutic agents, including antitumor drugs and neurological treatments. It is also used in industrial applications such as water treatment and chemical manufacturing.
A: Leache supplies 1,3-Dihydroxymethyl-5,5-Dimethylhydantoin with a purity of ≥99%, making it suitable for demanding pharmaceutical synthesis and research applications.
A: Standard packaging includes 25kg drums and 500kg containers on pallets. Custom packaging options are available upon request.
A: Leache has been manufacturing hydantoin series products for over 30 years and is the first domestic company to produce and sell these products in China.
A: Leache is a National High-Tech Enterprise and holds multiple patents and international certifications. Specific certifications vary by product and can be provided upon request.
A: Yes. Customers can specify packaging preferences, and labels and logos are interchangeable. Custom packaging solutions are available for bulk orders.
1,3-Dihydroxymethyl-5,5-Dimethylhydantoin is a versatile and high-purity pharmaceutical intermediate with applications spanning drug synthesis, industrial chemicals, and research. Its consistent quality and reliable performance make it a valuable component for manufacturers and researchers alike. Leache, with over 30 years of experience in hydantoin series products and a strong reputation in global markets, offers this compound with a commitment to quality, competitive pricing, and flexible packaging options. For more information or to request a quote, please contact us—we are ready to provide product details and support for your chemical sourcing needs.